Back
Greek Organisation of Football Prognostics SA Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
56
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$10.88
Seasonality Move:
4.04%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
56
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.80. The Score for GOFPY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $10.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
GOFPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 58.92 | Buy |
| Chaikin Money Flow: | -10315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.05 - 10.79) | Buy |
| Bollinger Bands (100): | (10.33 - 11.69) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.08 | Buy |
| Relative Strength Index (14 RSI): | 79.16 | Buy |
| Chaikin Money Flow: | -97373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 32.35) | Buy |
| Bollinger Bands (100): | (10.77 - 23.75) | Buy |
GOFPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.72 | Buy |
| 20-day SMA: | 10.56 | Buy |
| 50-day SMA: | 10.42 | Buy |
| 200-day SMA: | 10.91 | Sell |
| 8-day EMA: | 10.7 | Buy |
| 20-day EMA: | 10.58 | Buy |
| 50-day EMA: | 10.61 | Buy |
| 200-day EMA: | 10.57 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.51 | Buy |
| 20-day SMA: | 28.33 | Buy |
| 50-day SMA: | 21.67 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 28.99 | Buy |
| 50-day EMA: | 23.45 | Buy |
| 200-day EMA: | 17.42 | Buy |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||